Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial
Ulrich Hacker, Laura Escalona-Espinosa, Nicola Consalvo, et al.
British Journal of Cancer (2016) Vol. 114, Iss. 8, pp. 855-862
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Dai Fukumura, Jonas Kloepper, Zohreh Amoozgar, et al.
Nature Reviews Clinical Oncology (2018) Vol. 15, Iss. 5, pp. 325-340
Open Access | Times Cited: 1550
New agents on the horizon in gastric cancer
Florian Lordick, Kohei Shitara, Yelena Y. Janjigian
Annals of Oncology (2017) Vol. 28, Iss. 8, pp. 1767-1775
Open Access | Times Cited: 103
Angiogenesis and Anti-Angiogenic Therapy in Gastric Cancer
Henrik Nienhüser, Thomas Schmidt
International Journal of Molecular Sciences (2017) Vol. 19, Iss. 1, pp. 43-43
Open Access | Times Cited: 95
Anti-angiogenic Therapy in Patients with Advanced Gastric and Gastroesophageal Junction Cancer: A Systematic Review
Li‐Tzong Chen, Do‐Youn Oh, Min‐Hee Ryu, et al.
Cancer Research and Treatment (2017) Vol. 49, Iss. 4, pp. 851-868
Open Access | Times Cited: 65
Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions
Francesca Battaglin, Madiha Naseem, Alberto Puccini, et al.
Cancer Cell International (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 52
Tumor progression-dependent angiogenesis in gastric cancer and its potential application
Hsi‐Lung Hsieh, Ming-Ming Tsai
World Journal of Gastrointestinal Oncology (2019) Vol. 11, Iss. 9, pp. 686-704
Open Access | Times Cited: 50
MiR-145-5p suppresses the proliferation, migration and invasion of gastric cancer epithelial cells via the ANGPT2/NOD_LIKE_RECEPTOR axis
Kai Zhou, Binbin Song, Ming Wei, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 42
Tumor Microenvironment of Esophageal Cancer
Lars M. Schiffmann, Patrick Sven Plum, Hans F. Fuchs, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4678-4678
Open Access | Times Cited: 33
Biomarker analyses of second-line ramucirumab in patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 study
Eric Van Cutsem, Kei Muro, David Cunningham, et al.
European Journal of Cancer (2020) Vol. 127, pp. 150-157
Open Access | Times Cited: 34
Tumor Vessel Normalization: A Window to Enhancing Cancer Immunotherapy
Sai Li, Qi Zhang, Yupeng Hong
Technology in Cancer Research & Treatment (2020) Vol. 19
Open Access | Times Cited: 33
Molecular Targets for Gastric Cancer Treatment and Future Perspectives from a Clinical and Translational Point of View
Justus Körfer, Florian Lordick, Ulrich Hacker
Cancers (2021) Vol. 13, Iss. 20, pp. 5216-5216
Open Access | Times Cited: 28
Novel Biomarkers of Gastric Adenocarcinoma: Current Research and Future Perspectives
Nadja Niclauss, Ines Gütgemann, Jonas Dohmen, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5660-5660
Open Access | Times Cited: 27
Immunoregulation and clinical significance of neutrophils/NETs-ANGPT2 in tumor microenvironment of gastric cancer
Shifeng Yang, Xiaoming Zou, Jiacheng Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Doxorubicin-loaded PEGylated liposome modified with ANGPT2-specific peptide for integrative glioma-targeted imaging and therapy
Hongyan Li, Rong Gan, Jiadi Liu, et al.
Materials Today Bio (2025) Vol. 30, pp. 101455-101455
Open Access
Research progress on molecular mechanism of liver metastasis of gastric cancer and treatment with traditional Chinese medicine
Caiyue Liu, Zheng Li, F Cheng, et al.
Journal of Cancer (2025) Vol. 16, Iss. 6, pp. 1944-1957
Open Access
Angiogenesis inhibitors in early development for gastric cancer
Mauricio P. Pinto, Gareth I. Owen, Ignacio N. Retamal, et al.
Expert Opinion on Investigational Drugs (2017) Vol. 26, Iss. 9, pp. 1007-1017
Closed Access | Times Cited: 33
Prognostic and predictive factors for overall survival in metastatic oesophagogastric cancer: A systematic review and meta-analysis
Emil ter Veer, Jessy Joy van Kleef, Sandor Schokker, et al.
European Journal of Cancer (2018) Vol. 103, pp. 214-226
Closed Access | Times Cited: 31
Regional differences in advanced gastric cancer: exploratory analyses of the AVAGAST placebo arm
Akira Sawaki, Yasuhide Yamada, Kensei Yamaguchi, et al.
Gastric Cancer (2017) Vol. 21, Iss. 3, pp. 429-438
Open Access | Times Cited: 30
Targeted and immunotherapy in the era of personalised gastric cancer treatment
Silvia Catanese, Florian Lordick
Best Practice & Research Clinical Gastroenterology (2021) Vol. 50-51, pp. 101738-101738
Closed Access | Times Cited: 22
Early and late endothelial response in breast cancer metastasis in mice: simultaneous quantification of endothelial biomarkers using mass spectrometry-based method
Joanna Suraj, Anna Kurpińska, Agnieszka Zakrzewska, et al.
Disease Models & Mechanisms (2019)
Open Access | Times Cited: 24
Anti-angiogenic Targets: Angiopoietin and Angiopoietin Receptors
Elina A. Kiss, Pipsa Saharinen
Springer eBooks (2019), pp. 227-250
Closed Access | Times Cited: 24
Angpt2/Tie2 autostimulatory loop controls tumorigenesis
Ninelia Minaskan Karabid, Tobias Wiedemann, Sebastian Gulde, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 5
Open Access | Times Cited: 13
Gastric Cancer-Derived Extracellular Vesicles (EVs) Promote Angiogenesis via Angiopoietin-2
Talya Kalfon, Shelly Loewenstein, Fabian Gerstenhaber, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2953-2953
Open Access | Times Cited: 13
The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines
Annalisa Schirizzi, Marialessandra Contino, Livianna Carrieri, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Genomic markers of resistance to targeted treatments in gastric cancer: potential new treatment strategies
Alessandra Raimondi, Federico Nichetti, Giorgia Peverelli, et al.
Pharmacogenomics (2018) Vol. 19, Iss. 13, pp. 1047-1068
Closed Access | Times Cited: 22
Page 1 - Next Page

Scroll to top